The clinical relevance of thymic fluorodeoxyglucose uptake in pediatric patients after chemotherapy
- 13 February 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 31 (6), 831-836
- https://doi.org/10.1007/s00259-004-1466-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- [18F]FDG in childhood lymphoma: clinical utility and impact on managementEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Physiological FDG uptake in the palatine tonsilsAnnals of Nuclear Medicine, 2001
- False-positive F-18 FDG gamma camera positron emission tomographic imaging resulting from inflammation of an anterior mediastinal mass in a patient with non-Hodgkin's lymphoma.Published by Rockefeller University Press ,2001
- Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncologyNuclear Medicine Communications, 1999
- False-positive FDG-PET imaging of the thymus of a child with Hodgkin's disease.1997
- Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretationSeminars in Nuclear Medicine, 1996
- Lymphocyte depletion during treatment with intensive chemotherapy for cancer.1994
- Thymic atrophy and regrowth in response to chemotherapy: CT evaluationAmerican Journal of Roentgenology, 1987
- Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.1986
- Diffuse thymic hyperplasia following chemotherapy for nodular sclerosing Hodgkin's disease: An immunologic rebound phenomenon?Cancer, 1983